Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma. - Suppr | 超能文献

Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.

作者信息

Schwarz L R

出版信息

Cancer. 1996 Aug 1;78(3):566-7. doi: 10.1002/(SICI)1097-0142(19960801)78:3<566::AID-CNCR27>3.0.CO;2-W.

DOI:10.1002/(SICI)1097-0142(19960801)78:3<566::AID-CNCR27>3.0.CO;2-W

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.

Cancer. 1996 Aug 1;78(3):566-7. doi: 10.1002/(SICI)1097-0142(19960801)78:3<566::AID-CNCR27>3.0.CO;2-W.

2

Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.

Cancer. 1995 Dec 1;76(11):2186-92. doi: 10.1002/1097-0142(19951201)76:11<2186::aid-cncr2820761103>3.0.co;2-y.

3

Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.

Semin Oncol. 1996 Oct;23(5 Suppl 11):32-7.

4

A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.

Anticancer Res. 2002 Nov-Dec;22(6B):3621-7.

5

Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma.

J Infus Chemother. 1996 Fall;6(4):217-20.

6

Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.

Head Neck. 2003 Jun;25(6):438-50. doi: 10.1002/hed.10238.

7

Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).

Cancer. 1996 Sep 15;78(6):1300-7. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1300::AID-CNCR19>3.0.CO;2-4.

8

Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.

J Urol. 2007 Jan;177(1):84-9; discussion 89. doi: 10.1016/j.juro.2006.08.058.

9

Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.

Br J Cancer. 1999 Aug;80(12):1962-7. doi: 10.1038/sj.bjc.6690627.

10

[Continuous infusion high-dose leucovorin with cisplatin and 5-fluorouracil for a recurrent oropharynx carcinoma].

Gan To Kagaku Ryoho. 1997 Apr;24(6):719-21.

引用本文的文献

1

Cost-effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin in the first-line setting for Chinese patients with metastatic nasopharyngeal carcinoma.

Eur Arch Otorhinolaryngol. 2020 Feb;277(2):577-584. doi: 10.1007/s00405-019-05714-z. Epub 2019 Nov 12.

2

Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma.

J Cancer Res Clin Oncol. 2012 Oct;138(10):1717-25. doi: 10.1007/s00432-012-1219-x. Epub 2012 Jun 10.